Comments
Drugmaker Lupin has launched its Amlodipine and Valsartan tablets, used for treatment of hypertension, in the U.S. market after getting approval from the American health regulator.
The U.S. arm of the company, Lupin Pharmaceuticals Inc, has launched Amlodipine and Valsartan tablets in various strengths in the U.S. market after getting final approval from the United States Food and Drug Administration (USFDA), Lupin said in a statement.
Lupin’s Amlodipine and Valsartan tablets are indicated for the treatment of hypertension and to lower blood pressure and are the generic version of Novarts Pharmaceuticals Corporation’s Exforge tablets.
As per IMS MAT sales data, Exforge tablets had U.S. sales of US$ 414.9 million.
With this approval, the Mumbai-based firm has received six abbreviated new drug approvals (ANDAs) in the last three months.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.